Pharmacogenomics | OMICS International | Internal Medicine Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


Pharmacogenomics is the study of how person's response to drug is affected by the gene. pharmacogenomics is a combination of pharmacology (drug science) and genomics (study of genes and their functions). The main of pharmacogenomics is to develop safe, effective medications and doses that will be sufficient to a persons genetic makeup. Doctors are starting using pharmacogenomics information for prescribing the drugs, but such tests are useful only for few health problems. However, with rapid growth in the field, pharmacogenomics is soon expected to lead to better ways of using drugs in managing several diseases like cancer, heart disease, depression, asthma, and many other common diseases. Internal Medicine Open Access Journal publishes almost all the papers related to Disorders. The journal has a highly qualified professors and associate professors as its editorial board members. These experts after thorough peer review process will make a decision whether a manuscript can be accepted for publication or not.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021